Abramov; Mili

Patent Applications and Registrations

Patent applications and USPTO patent grants for Abramov; Mili.The latest application filed is for "crystalline forms of sitagliptin phosphate".

Company Profile

0.6.19

Abramov; Mili - Givataim IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amorphous carvedilol dihydrogen phosphate Grant 8,114,900 - Ini , et al. February 14, 2	2012-02-14
Carvedilol phosphate Grant 8,022,094 - Ini , et al. September 20, 2	2011-09-20
DNT-maleate and methods of preparation thereof Grant 7,842,717 - Ini , et al. November 30, 2	2010-11-30
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride Grant 7,759,500 - Ini , et al. July 20, 2	2010-07-20
Crystalline Forms Of Sitagliptin Phosphate App 20100041885 - Perlman; Nurit ; et al.	2010-02-18
Carvedilol phosphate App 20090286844 - Ini; Santiago ; et al.	2009-11-19
Preparation of sitagliptin intermediate App 20090192326 - Perlman; Nurit ; et al.	2009-07-30
Process for the preparation of (S)-(-)-N,N-dimethyl-3-(2-thienyl)-3-hydroxypropananine, a duloxetine intermediate Grant 7,560,573 - Ini , et al. July 14, 2	2009-07-14
Process for the purification of duloxetine hydrochloride Grant 7,534,900 - Ini , et al. May 19, 2	2009-05-19
Pure DNT-maleate and methods of preparation thereof App 20080207923 - Ini; Santiago ; et al.	2008-08-28
Carvedilol phosphate App 20080125476 - Ini; Santiago ; et al.	2008-05-29
Solifenacin base forms and preparation thereof App 20080114171 - Koltai; Tamas ; et al.	2008-05-15
Process for preparing polymorphic forms of solifenacin succinate App 20080114028 - Koltai; Tamas ; et al.	2008-05-15
Process for the preparation of (S)-(-)-N,N-dimethyl-3-(2-thienyl)-3-hydroxypropananine, a duloxetine intermediate App 20080015363 - Ini; Santiago ; et al.	2008-01-17
Process for preparing duloxetine and intermediates thereof App 20070281989 - Ini; Santiago ; et al.	2007-12-06
Process for the preparation of(s)-(+)-N,N-dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)propanamine, A duloxetine intermediate App 20070238883 - Ini; Santiago ; et al.	2007-10-11
DNT-fumarate and methods of preparation thereof App 20070191471 - Ini; Santiago ; et al.	2007-08-16
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride App 20070191472 - Ini; Santiago ; et al.	2007-08-16
DNT-maleate and methods of preparation thereof App 20070185192 - Ini; Santiago ; et al.	2007-08-09
DNT-benzenesulfonate and methods of preparation thereof App 20070173540 - Ini; Santiago ; et al.	2007-07-26
DNT-succinate and methods of preparation thereof App 20070173541 - Ini; Santiago ; et al.	2007-07-26
Process for the purification of duloxetine hydrochloride App 20060276660 - Ini; Santiago ; et al.	2006-12-07
Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine App 20060270861 - Ini; Santiago ; et al.	2006-11-30
Pure duloxetine hydrochloride App 20060270731 - Ini; Santiago ; et al.	2006-11-30
(S)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof App 20060258871 - Ini; Santiago ; et al.	2006-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.